Compare RM & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RM | CBLL |
|---|---|---|
| Founded | 1987 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.7M | 428.8M |
| IPO Year | 2012 | 2024 |
| Metric | RM | CBLL |
|---|---|---|
| Price | $37.31 | $17.08 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $30.00 | $24.20 |
| AVG Volume (30 Days) | 52.1K | ★ 422.3K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | ★ 71.26 | N/A |
| EPS | ★ 4.13 | N/A |
| Revenue | ★ $610,145,000.00 | $82,813,000.00 |
| Revenue This Year | $16.06 | $35.50 |
| Revenue Next Year | $6.56 | $28.24 |
| P/E Ratio | $9.04 | ★ N/A |
| Revenue Growth | 9.60 | ★ 37.93 |
| 52 Week Low | $25.41 | $10.01 |
| 52 Week High | $46.00 | $32.75 |
| Indicator | RM | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 44.65 | 73.99 |
| Support Level | $35.93 | $16.27 |
| Resistance Level | $39.68 | $17.39 |
| Average True Range (ATR) | 1.45 | 0.74 |
| MACD | 0.10 | 0.40 |
| Stochastic Oscillator | 37.15 | 91.25 |
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.